Share tips of the week – 24 September
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Five to buy
JD Sports Fashion
(Investors’ Chronicle) JD Sports Fashion has benefited from the US government’s stimulus package: the American business produced over half of the group’s pre-tax profit of £439.5m in the first six months of 2021. That’s a sevenfold increase from the same period last year and 177% higher than in 2019. The group has completed a string of successful acquisitions across the US, Poland, Spain and Britain, which have helped drive growth. Its core UK and Ireland business did well despite new lockdowns; when shops were closed in the spring it made 90% of the sales it generated in the same period in 2019 from online sales. The firm remains cautious, forgoing an interim dividend in case of further lockdowns, but a larger full-year dividend is in prospect should positive trading continue. 1,151p
Darktrace
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Daily Telegraph) Around 15% of cybersecurity company Darktrace’s shares are owned by Mike Lynch, “a man accused of a multibillion dollar fraud”. But there is no sign of dubious practice at Darktrace. Since it listed in April the stock has tripled. The company faces stiff competition from American rivals. But it stands out because its software analyses users instead of devices, providing customers with a “map”, or visualisation, of their networks that makes it easier to spot anomalies. The firm has plenty of potential, and taking “a small punt” on it at this stage could pay off. 728p
Artisanal Spirits Company
(The Mail on Sunday) The Scotch Malt Whisky Society was founded in 1983 by Edinburgh’s Pip Hills and 12 of his friends, so that they could buy and enjoy casks of whisky. It now boasts 29,000 members and listed on Aim in June as the Artisanal Spirits Company. Members pay around £65 a year and most buy at least seven bottles averaging £75 each. First half figures for 2021 revealed sales of £7.9m, a 20% year-on-year rise. Analysts expect revenues of £17.5m for 2021 and £21m next year. The group is expected to be profitable from next year and the whisky market is booming. The shares have dipped recently, but given the firm’s solid prospects, they should recover. 83p
CVC
(The Sunday Times) Pets have become a big business following the pandemic. Complex procedures and “posh pet food” have become widely available, driving rapid growth among insurers, pet shops and veterinary practices. CVS Group is an Aim-listed owner of vet surgeries. It recently acquired a majority stake in vet chain Medivet for £1bn and will continue to concentrate on acquisitions. Like-for-like sales for the 12 months to June jumped by 17.4%. For now, at least, pet owners are spending large sums on their animals while taking out insurance for them, too. The coming months will reveal whether the pet trend begins to slow, but if CVS continues to perform, it is one to buy. 2,490p
Chemring
(Shares) Defence group Chemring says its order book has grown, “providing visibility” for the remainder of the year and fuelling confidence that it will meet analysts’ expectations for the year to 31 October. The order book was valued at £464m in August, up from £450m at the end of April. The company’s cybersecurity subsidiary, Roke, should keep flourishing as the sector expands: further double-digit growth is expected. Orders for 2022 are building too. The stock’s quality and “ongoing resilience” make it a buy. 328p
...and the rest
The Daily Telegraph
B&Q owner Kingfisher’s like-for-like sales were 5% higher year-on-year in June, compared with a 2% rise for the overall market. The group has an “above average” chance of maintaining its edge over rivals. Lockdown was a huge boost for home improvement and the pandemic introduced many people to “the joys of DIY”. Hold (371p).
Shares
Recent acquisitions by refuse-specialist Biffa have cemented its lead in waste-recycling. It has recovered from the crisis more rapidly than expected: revenue for the first five months of the year to 31 August was 12% higher than in the same period of 2019. Earnings forecasts for 2022 and 2023 have risen strongly recently. Buy (385p).
Investors’ Chronicle
Higher demand from private patients boosted operating profits at Spire Healthcare Group, Britain’s second-biggest private provider, to £46.2m in the six months to 30 June 2021; the previous year it made a loss. Demand should remain robust. Hold (236p).
The Mail on Sunday
Palm oil “is a controversial commodity” but Indonesia-based MP Evans prides itself on sustainable production, proper treatment of workers and supporting local communities. The company looks after investors too: it has maintained or increased its dividend every year for the last 25 years. The firm has announced a 588% increase in half-year profits to £30m and a doubling of the interim dividend to 10p. It has also pledged to increase the annual dividend by 36% to 30p. Existing shareholders should hold, and new investors “could dip their toes in”(788p).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves